Heroin reward is dependent on a dopaminergic substrate - PubMed (original) (raw)
Heroin reward is dependent on a dopaminergic substrate
M A Bozarth et al. Life Sci. 1981.
No abstract available
Similar articles
- Effects of naloxone on heroin-, amphetamine- and caffeine-stimulated locomotor activity in the rat.
Swerdlow NR, Vaccarino FJ, Koob GF. Swerdlow NR, et al. Pharmacol Biochem Behav. 1985 Sep;23(3):499-501. doi: 10.1016/0091-3057(85)90028-0. Pharmacol Biochem Behav. 1985. PMID: 4048244 - Neuroleptic-induced "anhedonia" in rats: pimozide blocks reward quality of food.
Wise RA, Spindler J, deWit H, Gerberg GJ. Wise RA, et al. Science. 1978 Jul 21;201(4352):262-4. doi: 10.1126/science.566469. Science. 1978. PMID: 566469 - Morphine-induced rotation in naive, nonlesioned rats.
Jacquet YF, Carol M, Russell IS. Jacquet YF, et al. Science. 1976 Apr 16;192(4236):261-3. doi: 10.1126/science.1257766. Science. 1976. PMID: 1257766 - Quasi morphine-abstinence syndrome.
Collier HO, Francis DL, Henderson G, Schneider C. Collier HO, et al. Nature. 1974 May 31;249(456):471-3. doi: 10.1038/249471a0. Nature. 1974. PMID: 4545823 No abstract available. - Activation of serotonin 5-HT(2C) receptor suppresses behavioral sensitization and naloxone-precipitated withdrawal symptoms in heroin-treated mice.
Wu X, Pang G, Zhang YM, Li G, Xu S, Dong L, Stackman RW Jr, Zhang G. Wu X, et al. Neurosci Lett. 2015 Oct 21;607:23-28. doi: 10.1016/j.neulet.2015.09.013. Epub 2015 Sep 12. Neurosci Lett. 2015. PMID: 26375926 Free PMC article.
Cited by
- Increased functional connectivity in the resting-state basal ganglia network after acute heroin substitution.
Schmidt A, Denier N, Magon S, Radue EW, Huber CG, Riecher-Rossler A, Wiesbeck GA, Lang UE, Borgwardt S, Walter M. Schmidt A, et al. Transl Psychiatry. 2015 Mar 24;5(3):e533. doi: 10.1038/tp.2015.28. Transl Psychiatry. 2015. PMID: 25803496 Free PMC article. - Animal models of drug withdrawal symptoms.
Emmett-Oglesby MW, Mathis DA, Moon RT, Lal H. Emmett-Oglesby MW, et al. Psychopharmacology (Berl). 1990;101(3):292-309. doi: 10.1007/BF02244046. Psychopharmacology (Berl). 1990. PMID: 1972994 Review. - The effects of dopamine D1 and D2 receptor antagonists on the rewarding effects of delta 1 and delta 2 opioid receptor agonists in mice.
Suzuki T, Tsuji M, Mori T, Misawa M, Nagase H. Suzuki T, et al. Psychopharmacology (Berl). 1996 Apr;124(3):211-8. doi: 10.1007/BF02246659. Psychopharmacology (Berl). 1996. PMID: 8740041 - High Genetic Addiction Risk Score (GARS) in Chronically Prescribed Severe Chronic Opioid Probands Attending Multi-pain Clinics: an Open Clinical Pilot Trial.
Moran M, Blum K, Ponce JV, Lott L, Gondré-Lewis MC, Badgaiyan S, Brewer R, Downs BW, Fynman P, Weingarten A, Cadet JL, Smith DE, Baron D, Thanos PK, Modestino EJ, Badgaiyan RD, Elman I, Gold MS. Moran M, et al. Mol Neurobiol. 2021 Jul;58(7):3335-3346. doi: 10.1007/s12035-021-02312-1. Epub 2021 Mar 8. Mol Neurobiol. 2021. PMID: 33683627 Free PMC article. Clinical Trial. - Complex motor and sensorimotor functions of striatal and accumbens dopamine: involvement in instrumental behavior processes.
Salamone JD. Salamone JD. Psychopharmacology (Berl). 1992;107(2-3):160-74. doi: 10.1007/BF02245133. Psychopharmacology (Berl). 1992. PMID: 1615120 Review.